🔎 Trials Near Me

Akèy › Leksemi limfoblastik egi › Ohio › Columbus

Etid klinik pou Leksemi limfoblastik egi nan Columbus, OH

11 etid pou Leksemi limfoblastik egi ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • ak 8 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Ap rekriteFaz 1/2
  • Ohio State University, Columbus
30 Days · Tout sèks · Mizajou Sep 16, 2026 · NCT04065399

Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia

Ap rekriteFaz 1/2
  • The James Cancer Hospital and Solove Research Institute, Columbus
Laj 16 a 75 · Tout sèks · Mizajou Sep 10, 2026 · NCT03104491

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Ap rekriteEtid obsèvasyon
  • Nationwide Children's Hospital, Columbus
  • The Arthur G. James Cancer Hospital/The Ohio State University Medical Center, Columbus
Tout laj · Tout sèks · Mizajou Jul 6, 2026 · NCT01351545

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Ap rekriteFaz 1
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 2 ak plis · Tout sèks · Mizajou May 29, 2026 · NCT05418088

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Ap rekriteFaz 1
  • The Ohio State University, Columbus
Laj 13 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT04771572

Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide

Ap rekriteFaz 1
  • Ohio State University Medical Center, Columbus
Laj 18 a 65 · Tout sèks · Mizajou Mar 25, 2026 · NCT03533816

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Ap rekriteFaz 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Laj 12 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT04988555

HPC Offered for PRESERVE Expansion

Ap rekriteEtid obsèvasyon
  • The Ohio State University Medical Center, Columbus
Laj 12 a 80 · Tout sèks · Mizajou Aug 28, 2025 · NCT07145411

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Nationwide Children's Hospital, Columbus
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Leksemi limfoblastik egi nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.